Chromo Laboratories India Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is ROSUVASTATIN CALCIUM USP, with a corresponding US DMF Number 37220.
Remarkably, this DMF maintains an Active status since its submission on April 26, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 27, 2026, and payment made on December 05, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II